Company Filing History:
Years Active: 2014
Title: The Innovations of Maurice Needham
Introduction
Maurice Needham is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing disorders associated with interleukin 17, a key player in various inflammatory conditions.
Latest Patents
Maurice Needham holds a patent titled "Antibodies to IL-17A and uses thereof." This patent involves binding members, especially antibody molecules, for interleukin 17 (IL-17). The binding members are particularly useful for the treatment of disorders such as rheumatoid arthritis, showcasing the potential impact of his innovations on healthcare.
Career Highlights
Needham is associated with MedImmune Limited, a prominent company in the biopharmaceutical sector. His role at MedImmune has allowed him to contribute to groundbreaking research and development in therapeutic solutions. His expertise in antibody technology has positioned him as a valuable asset in the fight against autoimmune diseases.
Collaborations
Throughout his career, Maurice has collaborated with esteemed colleagues, including Duncan James Cochrane and Caroline S. Russell. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their field.
Conclusion
Maurice Needham's work exemplifies the vital role of inventors in advancing medical science. His patent on antibodies to IL-17A represents a significant step forward in treating inflammatory disorders. The impact of his contributions will likely resonate in the medical community for years to come.